Adial raises $2.75M via warrant inducement; existing warrants exercised at $0.74

ADIAL PHARMACEUTICALS, INC.

Existing Series B and C warrants for 3,718,440 shares exercised at reduced price of $0.74 per share.
Company issued new unregistered Series B-1 (2.48M shares) and C-1 (4.03M shares) warrants at $0.74 exercise price.
New warrants exercisable only after stockholder approval; Series B-1 expire in 5 years, C-1 in 18 months.
Net proceeds to be used for working capital and general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.